Translation
	October 17, 2006
	Name of listed company:   Chugai Pharmaceutical Co., Ltd. Code number: 4519 (1st Section of Tokyo Stock Exchange) Head office: 1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo President & CEO: Osamu Nagayama Inquiries to: Mamoru Togashi, General Manager, Corporate Communications Dept.   Tel:+81-(0)3-3273-0881

F. Hoffmann-La Roche Announces Third Quarter Sales 2006

F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. Chairman and CEO: Franz B. Humer] announced today, its third quarter sales 2006 (January 1 - September 30, 2006). Roche owns 50.1% of Chugai's outstanding shares (50.6% of voting rights) since October 1, 2002 (as of June 30, 2006).
Its presentation materials can be found on its Website (http://www.roche.com).

Chugai's sales for the period of January 1 to September 30, 2006 are included in the announced Roche Group's sales. These results are based on Roche's accounting policies which conform to International Financial Reporting Standards, which differ from generally accepted accounting standards in Japan.

Chugai's third quarter results for fiscal 2006 (January - September, 2006) are scheduled to be announced on October 24, 2006.